Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

What Factors Necessitate Removal of Retained Ballistic Fragments in the Head and Neck?

Vorrasi J, Calvi R, Lv M, Hammond R.

J Oral Maxillofac Surg. 2018 Apr;76(4):819-825. doi: 10.1016/j.joms.2017.11.033. Epub 2017 Dec 5.

PMID:
29288648
2.

Incorporating Simulation Into Oral and Maxillofacial Surgery Residency Education and Training: Christiana Care's Method.

Coffey-Zern S, Calvi RM, Vorrasi JS, Meara DJ.

J Oral Maxillofac Surg. 2015 Jul;73(7):1244-5. doi: 10.1016/j.joms.2015.02.011. Epub 2015 Feb 19. No abstract available.

PMID:
25957875
3.

Ion chemistry of 1H-1,2,3-triazole.

Ichino T, Andrews DH, Rathbone GJ, Misaizu F, Calvi RM, Wren SW, Kato S, Bierbaum VM, Lineberger WC.

J Phys Chem B. 2008 Jan 17;112(2):545-57. Epub 2007 Oct 26.

PMID:
17960930
4.

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).

Tarella C, Zanni M, Di Nicola M, Patti C, Calvi R, Pescarollo A, Zoli V, Fornari A, Novero D, Cabras A, Stella M, Comino A, Remotti D, Ponzoni M, Caracciolo D, Ladetto M, Magni M, Devizzi L, Rosato R, Boccadoro M, Bregni M, Corradini P, Gallamini A, Majolino I, Mirto S, Gianni AM; Gruppo Italiano Terapie Innovative nei Linfomi.

Leukemia. 2007 Aug;21(8):1802-11. Epub 2007 Jun 7.

PMID:
17554382
5.

Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.

Ricca I, Rocci A, Drandi D, Francese R, Compagno M, Lobetti Bodoni C, De Marco F, Astolfi M, Monitillo L, Vallet S, Calvi R, Ficara F, Omedè P, Rosato R, Gallamini A, Marinone C, Bergui L, Boccadoro M, Tarella C, Ladetto M.

Leukemia. 2007 Apr;21(4):697-705. Epub 2007 Feb 15.

PMID:
17301820
6.

High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.

Vitolo U, Liberati AM, Cabras MG, Federico M, Angelucci E, Baldini L, Boccomini C, Brugiatelli M, Calvi R, Ciccone G, Genua A, Deliliers GL, Levis A, Parvis G, Pavone E, Salvi F, Sborgia M, Gallo E; Intergruppo Italiano Linfomi.

Haematologica. 2005 Jun;90(6):793-801.

7.

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.

Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Morabito F, Martelli M, Brusamolino E, Iannitto E, Zaja F, Cortelazzo S, Rigacci L, Devizzi L, Todeschini G, Santini G, Brugiatelli M, Federico M; Intergruppo Italiano Linfomi.

Blood. 2004 Apr 1;103(7):2474-9. Epub 2003 Nov 26.

PMID:
14645001
8.

Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.

Vitolo U, Botto B, Capello D, Vivenza D, Zagonel V, Gloghini A, Novero D, Parvis G, Calvi R, Ariatti C, Milan I, Bertini M, Boccomini C, Freilone R, Pregno P, Orsucci L, Palestro G, Saglio G, Carbone A, Gallo E, Gaidano G.

Leukemia. 2002 Feb;16(2):268-75.

9.

The Influence of advanced age on the treatment and prognosis of diffuse large-cell lymphoma (DLCL).

Bertini M, Boccomini C, Calvi R.

Clin Lymphoma. 2001 Mar;1(4):278-84. Review.

PMID:
11707842
10.

Burkitt's lymphomas in adults: retrospective analysis of 30 cases treated with two different schemes.

Calvi R, Bertini M, Boccomini C, Botto B, Orsucci L, Vitolo U.

Haematologica. 1999 Apr;84(4):383-4. No abstract available.

11.

Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.

Vitolo U, Gaidano G, Botto B, Volpe G, Audisio E, Bertini M, Calvi R, Freilone R, Novero D, Orsucci L, Pastore C, Capello D, Parvis G, Sacco C, Zagonel V, Carbone A, Mazza U, Palestro G, Saglio G, Resegotti L.

Ann Oncol. 1998 Jan;9(1):55-61.

PMID:
9541684
12.

Mantle cell lymphoma: a retrospective study on 27 patients. Clinical features and natural history.

Bertini M, Rus C, Freilone R, Botto B, Calvi R, Novero D, Orsucci L, Vitolo U, Palestro G, Resegotti L.

Haematologica. 1998 Apr;83(4):312-6.

13.

Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin).

Bertini M, Freilone R, Botto B, Calvi R, Gallamini A, Gatti AM, Liberati AM, Meneghini V, Orlandi E, Orsucci L, Pizzuti M, Rota Scalabrini D, Salvi F, Todeschini G, Vitolo U, Resegotti L.

Haematologica. 1997 May-Jun;82(3):309-13.

14.

Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphoma.

Freilone R, Botto B, Vitolo U, Bertini M, Audisio E, Calvi R, Cucchi M, De Crescenzo A, Gallamini A, Ghio R, Griso L, Levis A, Massara G, Orsucci L, Ricardi U, Rota Scalabrini D, Salvi F, Secondo V, Resegotti L.

Ann Oncol. 1996 Nov;7(9):919-24.

PMID:
9006742
15.

Kinetics of calcium metabolism.

Alonso GL, Nikonov JM, Mestorino RJ, Calvi R.

Acta Physiol Lat Am. 1965;15(4):333-43. No abstract available.

PMID:
5871663

Supplemental Content

Support Center